Dristan Cold Multisymptom
Pricing Report NDC 0573-1238-21

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Dristan Cold Multisymptom (NDC 0573-1238-21) is $0.19332 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2015.

As a provided by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.19332
Per EA

Effective Date
Sep 23, 2015
Billable Units
2 EA
Estimated Package Price
$0.39
Data Status
As of Nov 18, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
2 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
Generic Benchmark
The generic equivalent rate is $0.07221 (Effective: Nov 18, 2015)
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.19297 to $0.20076 per EA. Over this 1 year and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1930 - $0.2008
Market Volatility
4.04% Variance
Latest Trend
2.58%
Date Unit Price Unit Source Method Rate
Sep 23, 2015 $0.19332 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 23, 2015 $0.19332 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Sep 23, 2015 $0.19332 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jul 22, 2015 $0.19843 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 22, 2015 $0.19843 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jun 17, 2015 $0.19425 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Aug 20, 2014 $0.19297 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jul 23, 2014 $0.19498 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 21, 2014 $0.20021 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 21, 2014 $0.20021 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 22, 2014 $0.19366 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 22, 2014 $0.19366 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 22, 2014 $0.19366 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 22, 2014 $0.19366 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Dec 18, 2013 $0.19408 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 24, 2013 $0.20076 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026